低剂量奎平的代谢不良影响:系统性审查和元分析
Pedro Sonim1, Rui M Ferreira1, Inês Lourenço2
1Faculty of Medicine, University of Porto, Porto, Portugal.
低剂量的奎平,第二代抗精神病药物,显著增加体重并降低高密度胆固醇. 这表明,即使降低剂量,对患者的新陈代谢也有显著影响.
科学领域:
- 药理学 药理学是指药理学的学科.
- 代谢医学是一种代谢医学.
- 临床精神病学 临床精神病学
背景情况:
- 越来越多地使用低剂量第二代抗精神病药物 (SGA),特别是氨酸,需要了解它们的代谢作用.
- SGA与不良的代谢结果有关,包括体重增加.
研究的目的:
- 系统地审查和元分析低剂量奎蒂亚平对代谢结果的影响.
- 评估对体重,血糖控制和脂质代谢的影响.
主要方法:
- 在多个数据库 (PubMed,科学网,Cochrane等) 中进行系统搜索. 对于随机对照试验.
- 纳入标准:试验>4周,奎平<200毫克,报告代谢结果.
- 使用RoB2评估的偏差风险;使用SPSS.数据汇总的数据.
主要成果:
- 六项研究 (n=3085) 进行了元分析,显示低剂量奎平显著增加体重 (MD=0.58公斤).
- 观察到HDL胆固醇的显著降低 (MD=-1.25 mg/dL).
- 服用奎平的患者增加≥7%的基线体重的可能性是2.12倍.
结论:
- 低剂量的奎平会影响患者的新陈代谢,影响体重和脂质状况.
- 需要进一步的研究,以充分阐明奎平在代谢失调中的作用.
- 在PROSPERO注册的研究 (CRD420250588527).
更多相关视频
04:33Author Spotlight: Unveiling the Connection Between Sleep Disorders and Cognitive Symptoms in Depression
Published on: April 26, 2024
08:15Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model
Published on: June 6, 2025
相关概念视频
Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance
A study on guinea pigs examined the...
Antidepressant Drugs: MAOIs and Other Agents
Sedatives and Hypnotics Drugs: Miscellaneous Agents
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Antiepileptic Drugs: Potassium Channel Activators
Ezogabine has gained approval as an adjunctive treatment...
Antipsychotic Drugs: Typical and Atypical Agents
Antipsychotic Drugs: Therapeutic Uses and Side Effects
Despite these side effects, antipsychotics are used therapeutically for various purposes, including managing schizophrenia, preventing nausea and vomiting, curbing...
